BURLINGTON, N.C., Feb. 11, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® ...
Innovative GFAP blood biomarker test expands Labcorp's (LH) portfolio of tests for diseases including Alzheimer's disease, multiple sclerosis, glioblastoma and brain injuries BURLINGTON, N.C., April ...
Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...
Labcorp has launched nationwide access to Agilent Technologies' PD-L1 IHC 22C3 pharmDx, the only FDA-approved companion diagnostic for identifying platinum-resistant ovarian cancer patients eligible ...
Pixel by Labcorp is a service offering various at-home and in-person tests for different health conditions. The tests come with step-by-step instructions, and the company works with independent ...
Labcorp is a science and healthcare company that provides laboratory testing services worldwide. It also functions as a lab facility that conducts research, clinical studies, diagnostic testing, and ...
Laboratory Corporation of America Holdings or LabCorp LH recently gained FDA emergency use authorization (EUA) for its VirSeq SARS-CoV-2 NGS (next-generation sequencing) Test on the PacBio Sequel II ...
Laboratory Corporation of America Holdings LH, known as LabCorp, recently launched the Labcorp Clinical Decision Support (CDS) interpretative test report for its Stinging Insect Component-Specific IgE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results